OMEN Pharma Researchers at the Department of Bioengineering (BE) at the Indian Institute of Science (IISc) have developed a promising 3D hydrogel culture system aimed at tackling drug-resistant tuberculosis (TB) and shortages of TB medicines. This innovation, which has been patented in India, could potentially revolutionize drug testing and discovery in the pharmaceutical industry. The new 3D … Read more
The Department of Pharmaceuticals (DoP) has given the green light for Rs. 243 crore in funding to establish Centers of Excellence (CoEs) within the National Institutes of Pharmaceutical Education and Research (NIPERs) for the upcoming fiscal year 2024-25. This initiative is part of the broader Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, … Read more
In a significant development for India’s pharmaceutical sector, small and medium enterprises (MSMEs) are poised for a major makeover under the revamped Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS). Dr. Arunish Chawla, Secretary of the Department of Pharmaceuticals (DoP), revealed that numerous companies are stepping up following comprehensive gap analyses. Dr. Chawla shared these insights during … Read more
Genmab A/S, a global biotechnology company focused on advancing patient care, has received positive news from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). They have recommended conditional marketing authorization for epcoritamab (Tepkinly), a novel T-cell engaging bispecific antibody. This recommendation is specifically for its use as a monotherapy in … Read more
The National Institutes of Health (NIH) is embarking on a groundbreaking clinical trial to assess the safety and effectiveness of an experimental monoclonal antibody aimed at combating enterovirus D68 (EV-D68), a virus linked to severe respiratory and neurological conditions such as acute flaccid myelitis (AFM), akin to polio. EV-D68 has been a growing concern in … Read more
Roche has received positive news from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), which has recommended the approval of PiaSky (crovalimab) for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). This recommendation marks a significant step forward in offering a new treatment option for adults and adolescents (12 years and older, … Read more
The European Medicines Agency’s committee for human medicines (CHMP) has made a critical decision regarding the medicine Ocaliva (obeticholic acid), recommending that its marketing authorization be revoked across the European Union. This decision comes after a thorough review concluded that the benefits of Ocaliva no longer outweigh its risks for the treatment of primary biliary … Read more
Merck, known as MSD outside of the United States and Canada, has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new drug Winrevair (sotatercept). This recommendation is for the treatment of pulmonary arterial hypertension (PAH) in adult patients with World Health … Read more
Venus Concept Inc, a global leader in medical aesthetic technology, has successfully concluded its series of NEXThetics events across major cities in North America. These gatherings have grown significantly in popularity and attendance, with thousands of registrants participating, including a record-setting event in Houston, Texas on June 22, 2024. Dr. Cheryl Haseeb from Pura Medical … Read more
Antengene Corporation Limited (Antengene), a prominent global biopharmaceutical company, has announced a significant milestone: South Korea’s National Health Insurance Service (NHIS) has approved reimbursement for Xpovio (selinexor) starting July 1, 2024. This approval marks Xpovio’s inclusion in South Korea’s national reimbursed drugs list for treating adult patients with relapsed or refractory multiple myeloma (R/R MM). … Read more
